David Judson Browning
Assistant Consulting Professor of Ophthalmology
Current Appointments & Affiliations
- Assistant Consulting Professor of Ophthalmology, Ophthalmology, Clinical Science Departments 1994
Contact Information
- 224 Wadsworth Bldg, Durham, NC 27710
- Box 3802 Med Ctr, Durham, NC 27710
-
(919) 684-8111
- Background
-
Education, Training, & Certifications
- PGY2, Ophthalmology, Duke University 1982 - 1985
- PGY1, Medicine, Duke University 1981 - 1982
- M.D., Duke University 1981
-
Previous Appointments & Affiliations
- Assistant Clinical Professor of Ophthalmology, Ophthalmology, Clinical Science Departments 1987 - 1988
- Publications & Artistic Works
-
Selected Publications
-
Books
-
Browning, D. J. Hydroxychloroquine and chloroquine retinopathy, 2014. https://doi.org/10.1007/978-1-4939-0597-3.Full Text
-
Browning, D. J. Retinal vein occlusions: Evidence-based management. Vol. 9781461434399, 2012. https://doi.org/10.1007/978-1-4614-3439-9.Full Text
-
Browning, D. J. Preface, 2010. https://doi.org/10.1007/978-0-387-85900-2.Full Text
-
-
Academic Articles
-
Jhaveri, Chirag D., Adam R. Glassman, Frederick L. Ferris, Danni Liu, Maureen G. Maguire, John B. Allen, Carl W. Baker, et al. “Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema.” N Engl J Med 387, no. 8 (August 25, 2022): 692–703. https://doi.org/10.1056/NEJMoa2204225.Full Text Link to Item
-
Rush, Ryan B., Sloan W. Rush, Robert M. Reinauer, Pedro Gomez Bastar, and David J. Browning. “VITRECTOMY FOR DIABETIC COMPLICATIONS: A Pooled Analysis of Randomized Controlled Trials Using Modern Techniques and Equipment.” Retina 42, no. 7 (July 1, 2022): 1292–1301. https://doi.org/10.1097/IAE.0000000000003471.Full Text Link to Item
-
Ozawa, Hiroko, Shinji Ueno, Akiko Ohno-Tanaka, Takao Sakai, Masayuki Hashiguchi, Mikiko Shimizu, Kaoru Fujinami, et al. “Ocular findings in Japanese patients with hydroxychloroquine retinopathy developing within 3 years of treatment.” Jpn J Ophthalmol 65, no. 4 (July 2021): 472–81. https://doi.org/10.1007/s10384-021-00841-9.Full Text Link to Item
-
Rosenfeld, Philip J., and David J. Browning. “Reply to Comment on: Is this a 737 Max Moment for Brolucizumab?” Am J Ophthalmol 223 (March 2021): 446–47. https://doi.org/10.1016/j.ajo.2020.06.034.Full Text Link to Item
-
Browning, David J., Naoto Yokogawa, Paul B. Greenberg, and Elliot Perlman. “Reply to Comment on: Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines.” Am J Ophthalmol 222 (February 2021): 400–401. https://doi.org/10.1016/j.ajo.2020.09.015.Full Text Link to Item
-
Yokogawa, Naoto, Akiko Ohno-Tanaka, Masayuki Hashiguchi, Mikiko Shimizu, Hiroko Ozawa, Shinji Ueno, Kei Shinoda, and David J. Browning. “Early-Onset Hydroxychloroquine Retinopathy and a Possible Relationship to Blood Levels: Comment on the Article by Petri et al.” Arthritis Rheumatol 73, no. 2 (February 2021): 358–59. https://doi.org/10.1002/art.41497.Full Text Link to Item
-
Browning, D. J., and P. B. Greenberg. “Quantifying conflict of interest in the choice of anti-vegf agents.” Clinical Ophthalmology 15 (January 1, 2021): 1403–8. https://doi.org/10.2147/OPTH.S298575.Full Text
-
Browning, David J., Naoto Yokogawa, Paul B. Greenberg, and Elliot Perlman. “Rethinking the Hydroxychloroquine Dosing and Retinopathy Screening Guidelines.” Am J Ophthalmol 219 (November 2020): 101–6. https://doi.org/10.1016/j.ajo.2020.06.030.Full Text Link to Item
-
Rosenfeld, Philip J., and David J. Browning. “Is This a 737 Max Moment for Brolucizumab?” Am J Ophthalmol 216 (August 2020): A7–8. https://doi.org/10.1016/j.ajo.2020.05.012.Full Text Link to Item
-
Mansour, S. E., D. J. Browning, K. Wong, H. W. Flynn, and A. R. Bhavsar. “The evolving treatment of diabetic retinopathy.” Clinical Ophthalmology 14 (January 1, 2020): 653–78. https://doi.org/10.2147/OPTH.S236637.Full Text
-
Nassar, S., A. K. Tarbett, and D. J. Browning. “Choroidal cavitary disorders.” Clinical Ophthalmology 14 (January 1, 2020): 2609–23. https://doi.org/10.2147/OPTH.S264731.Full Text
-
Browning, D. J., M. Easterbrook, and C. Lee. “The 2016 American Academy of Ophthalmology Hydroxychloroquine Dosing Guidelines For Short, Obese Patients.” Ophthalmology Retina 3, no. 10 (October 1, 2019): 809–13. https://doi.org/10.1016/j.oret.2019.05.005.Full Text
-
Punjabi, Omar S., David J. Browning, Loraine Clark, and Andrew N. Antoszyk. “"Pacman" invasion of the retina: Two cases of ophthalmomyiasis interna posterior.” Am J Ophthalmol Case Rep 15 (September 2019): 100491. https://doi.org/10.1016/j.ajoc.2019.100491.Full Text Link to Item
-
Baker, Carl W., Adam R. Glassman, Wesley T. Beaulieu, Andrew N. Antoszyk, David J. Browning, Kakarla V. Chalam, Sandeep Grover, et al. “Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial.” Jama 321, no. 19 (May 21, 2019): 1880–94. https://doi.org/10.1001/jama.2019.5790.Full Text Link to Item
-
Yu, Jeannette J., Elvira Agrón, Traci E. Clemons, Amitha Domalpally, Freekje van Asten, Tiarnan D. Keenan, Catherine Cukras, Emily Y. Chew, and Emily Y. Age-Related Eye Disease Study 2 Research Group. “Natural History of Drusenoid Pigment Epithelial Detachment Associated with Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report No. 17.” Ophthalmology 126, no. 2 (February 2019): 261–73. https://doi.org/10.1016/j.ophtha.2018.08.017.Full Text Link to Item
-
Browning, David J., Michael W. Stewart, and Chong Lee. “Diabetic macular edema: Evidence-based management.” Indian J Ophthalmol 66, no. 12 (December 2018): 1736–50. https://doi.org/10.4103/ijo.IJO_1240_18.Full Text Link to Item
-
Keenan, Tiarnan D., Elvira Agrón, Amitha Domalpally, Traci E. Clemons, Freekje van Asten, Wai T. Wong, Ronald G. Danis, et al. “Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16.” Ophthalmology 125, no. 12 (December 2018): 1913–28. https://doi.org/10.1016/j.ophtha.2018.05.028.Full Text Link to Item
-
Stewart, Michael W., David J. Browning, and Maurice B. Landers. “Current management of diabetic tractional retinal detachments.” Indian J Ophthalmol 66, no. 12 (December 2018): 1751–62. https://doi.org/10.4103/ijo.IJO_1217_18.Full Text Link to Item
-
Browning, David J. “Reply.” Am J Ophthalmol 191 (July 2018): 166–67. https://doi.org/10.1016/j.ajo.2018.04.003.Full Text Link to Item
-
Browning, David J. “Comparing Aflibercept Monotherapy With Aflibercept Plus Rescue Photodynamic Therapy in Polypoidal Choroidal Vasculopathy: PLANET or Asteroid?” Jama Ophthalmol 136, no. 7 (July 1, 2018): 794–95. https://doi.org/10.1001/jamaophthalmol.2018.1799.Full Text Link to Item
-
Jampol, Lee M., Adam R. Glassman, Danni Liu, Lloyd Paul Aiello, Neil M. Bressler, Elia J. Duh, Susan Quaggin, John A. Wells, Charles C. Wykoff, and Charles C. Diabetic Retinopathy Clinical Research Network. “Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema.” Ophthalmology 125, no. 7 (July 2018): 1054–63. https://doi.org/10.1016/j.ophtha.2018.01.019.Full Text Link to Item
-
Browning, D. J., and C. Lee. “Somatotype, the risk of hydroxychloroquine retinopathy, and safe daily dosing guidelines.” Clinical Ophthalmology 12 (May 3, 2018): 811–18. https://doi.org/10.2147/OPTH.S163451.Full Text
-
Browning, David J. “Physician Assistants and Nurse Practitioners in Ophthalmology-Has the Time Come?” Am J Ophthalmol 186 (February 2018): ix–xi. https://doi.org/10.1016/j.ajo.2017.09.023.Full Text Link to Item
-
Browning, David J. “Reply.” Am J Ophthalmol 186 (February 2018): 175–76. https://doi.org/10.1016/j.ajo.2017.11.023.Full Text Link to Item
-
Perlman, Elliot M., Paul B. Greenberg, David Browning, Robert P. Friday, and Joan W. Miller. “Solving the Hydroxychloroquine Dosing Dilemma With a Smartphone App.” Jama Ophthalmol 136, no. 2 (February 1, 2018): 218–19. https://doi.org/10.1001/jamaophthalmol.2017.6076.Full Text Link to Item
-
Maturi, Raj K., Adam R. Glassman, Danni Liu, Roy W. Beck, Abdhish R. Bhavsar, Neil M. Bressler, Lee M. Jampol, et al. “Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema: A DRCR Network Phase 2 Randomized Clinical Trial.” Jama Ophthalmol 136, no. 1 (January 1, 2018): 29–38. https://doi.org/10.1001/jamaophthalmol.2017.4914.Full Text Link to Item
-
Browning, David J. “Adopting the Results of Everest II Into Practice: A Clearer View From a Higher Level Study.” Jama Ophthalmol 135, no. 11 (November 1, 2017): 1214–15. https://doi.org/10.1001/jamaophthalmol.2017.3118.Full Text Link to Item
-
Hutton, David W., Joshua D. Stein, Neil M. Bressler, Lee M. Jampol, David Browning, Adam R. Glassman, and Adam R. Diabetic Retinopathy Clinical Research Network. “Cost-effectiveness of Intravitreous Ranibizumab Compared With Panretinal Photocoagulation for Proliferative Diabetic Retinopathy: Secondary Analysis From a Diabetic Retinopathy Clinical Research Network Randomized Clinical Trial.” Jama Ophthalmol 135, no. 6 (June 1, 2017): 576–84. https://doi.org/10.1001/jamaophthalmol.2017.0837.Full Text Link to Item
-
Browning, D. J., O. S. Punjabi, and C. Lee. “Authors’ reply.” Clinical Ophthalmology 11 (February 22, 2017): 410.
-
Browning, D. J., O. S. Punjabi, and C. Lee. “Assessment of ischemia in acute central retinal vein occlusion from inner retinal reflectivity on spectral domain optical coherence tomography.” Clinical Ophthalmology 11 (January 1, 2017): 71–79. https://doi.org/10.2147/OPTH.S122683.Full Text
-
Browning, David J. “Interpreting Database Studies-Reply.” Jama Ophthalmol 134, no. 11 (November 1, 2016): 1336. https://doi.org/10.1001/jamaophthalmol.2016.3252.Full Text Link to Item
-
Browning, D. J. “Reply.” American Journal of Ophthalmology 170 (October 1, 2016): 240–41. https://doi.org/10.1016/j.ajo.2016.07.007.Full Text
-
Browning, David J. “The Prevalence of Hydroxychloroquine Retinopathy and Toxic Dosing, and the Role of the Ophthalmologist in Reducing Both.” Am J Ophthalmol 166 (June 2016): ix–xi. https://doi.org/10.1016/j.ajo.2016.03.044.Full Text Link to Item
-
Browning, D. J., C. Lee, M. W. Stewart, and M. B. Landers. “Vitrectomy for center-involved diabetic macular edema.” Clinical Ophthalmology 10 (April 26, 2016): 735–42. https://doi.org/10.2147/OPTH.S104906.Full Text
-
Stewart, Michael W., Maurice B. Landers, David J. Browning, Toshinori Murata, Masahito Ohji, Jerzy Nawrocki, and Jay K. Chhablani. “Correspondence.” Retina 36, no. 3 (March 2016): e22–23. https://doi.org/10.1097/IAE.0000000000000957.Full Text Link to Item
-
Wells, John A., Adam R. Glassman, Lee M. Jampol, Lloyd Paul Aiello, Andrew N. Antoszyk, Carl W. Baker, Neil M. Bressler, et al. “Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema.” Jama Ophthalmol 134, no. 2 (February 2016): 127–34. https://doi.org/10.1001/jamaophthalmol.2015.4599.Full Text Link to Item
-
Browning, David J. “Vitrectomy for Proliferative Diabetic Retinopathy: Does Anyone Know the Complication Rate?” Jama Ophthalmol 134, no. 1 (January 2016): 86–87. https://doi.org/10.1001/jamaophthalmol.2015.4597.Full Text Link to Item
-
Writing Committee for the Diabetic Retinopathy Clinical Research Network, Roy W., Jeffrey G. Gross, Adam R. Glassman, Lee M. Jampol, Seidu Inusah, Lloyd Paul Aiello, Andrew N. Antoszyk, et al. “Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.” Jama 314, no. 20 (November 24, 2015): 2137–46. https://doi.org/10.1001/jama.2015.15217.Full Text Link to Item
-
Pautler, Scott E., and David J. Browning. “Re: Saksens et al.: Dominant cystoid macular dystrophy (Ophthalmology 2015;122:180-91).” Ophthalmology 122, no. 10 (October 2015): e59–60. https://doi.org/10.1016/j.ophtha.2015.02.042.Full Text Link to Item
-
Willoughby, Alex S., Gui-Shuang Ying, Cynthia A. Toth, Maureen G. Maguire, Russell E. Burns, Juan E. Grunwald, Ebenezer Daniel, Glenn J. Jaffe, and Glenn J. Comparison of Age-Related Macular Degeneration Treatments Trials Research Group. “Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials.” Ophthalmology 122, no. 9 (September 2015): 1846-53.e5. https://doi.org/10.1016/j.ophtha.2015.05.042.Full Text Link to Item
-
Browning, D. J., and C. Lee. “Scotoma analysis of 10–2 visual field testing with a red target in screening for hydroxychloroquine retinopathy.” Clinical Ophthalmology 9 (August 20, 2015): 1499–1509. https://doi.org/10.2147/OPTH.S87850.Full Text
-
Browning, David J., Scott E. Pautler, Keye L. Wong, David G. Telander, and Michael W. Stewart. “Re: Impact of Macula-off Retinal Detachment on Visual Outcome, A Systematic Review and Meta-Analysis of Literature.” Retina 35, no. 7 (July 2015): e44. https://doi.org/10.1097/IAE.0000000000000673.Full Text Link to Item
-
Pautler, Scott E., and David J. Browning. “Re: Pachychoroid neovasculopathy.” Retina 35, no. 7 (July 2015): e39–40. https://doi.org/10.1097/IAE.0000000000000661.Full Text Link to Item
-
Browning, D. J., and C. Lee. “Scotoma analysis of 10-2 visual field testing with a white target in screening for hydroxychloroquine retinopathy.” Clinical Ophthalmology 9 (May 25, 2015): 943–52. https://doi.org/10.2147/OPTH.S82398.Full Text
-
Diabetic Retinopathy Clinical Research Network, Roy W., John A. Wells, Adam R. Glassman, Allison R. Ayala, Lee M. Jampol, Lloyd Paul Aiello, Andrew N. Antoszyk, et al. “Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.” N Engl J Med 372, no. 13 (March 26, 2015): 1193–1203. https://doi.org/10.1056/NEJMoa1414264.Full Text Link to Item
-
Wong, K. L., S. E. Pautler, and D. J. Browning. “Near-infrared reflectance bull’s eye maculopathy as an early indication of hydroxychloroquine toxicity.” Clinical Ophthalmology 9 (March 19, 2015): 521–25. https://doi.org/10.2147/OPTH.S76963.Full Text
-
Elman, Michael J., Allison Ayala, Neil M. Bressler, David Browning, Christina J. Flaxel, Adam R. Glassman, Lee M. Jampol, Thomas W. Stone, and Thomas W. Diabetic Retinopathy Clinical Research Network. “Intravitreal Ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results.” Ophthalmology 122, no. 2 (February 2015): 375–81. https://doi.org/10.1016/j.ophtha.2014.08.047.Full Text Link to Item
-
Pautler, S. E., and D. J. Browning. “To the editor.” Retina 35, no. 7 (January 1, 2015): e39–40.
-
Pautler, S. E., and D. J. Browning. “Isolated posterior uveal effusion: Expanding the spectrum of the uveal effusion syndrome.” Clinical Ophthalmology 9 (December 30, 2014): 43–49. https://doi.org/10.2147/OPTH.S75448.Full Text
-
Browning, D. J., and C. Lee. “Test-retest variability of multifocal electroretinography in normal volunteers and short-term variability in hydroxychloroquine users.” Clinical Ophthalmology 8 (August 7, 2014): 1467–73. https://doi.org/10.2147/OPTH.S66528.Full Text
-
Browning, D. J., and C. Lee. “Relative sensitivity and specificity of 10-2 visual fields, multifocal electroretinography, and spectral domain optical coherence tomography in detecting hydroxychloroquine and chloroquine retinopathy.” Clinical Ophthalmology 8 (July 25, 2014): 1389–99. https://doi.org/10.2147/OPTH.S66527.Full Text
-
Browning, D. J., C. Lee, and D. Rotberg. “The impact of different algorithms for ideal body weight on screening for hydroxychloroquine retinopathy in women.” Clinical Ophthalmology 8 (July 24, 2014): 1401–7. https://doi.org/10.2147/OPTH.S66531.Full Text
-
Browning, David J. “Reply: To PMID 23218706.” Am J Ophthalmol 156, no. 2 (August 2013): 410–11. https://doi.org/10.1016/j.ajo.2013.04.011.Full Text Link to Item
-
Browning, David J. “Impact of the revised american academy of ophthalmology guidelines regarding hydroxychloroquine screening on actual practice.” Am J Ophthalmol 155, no. 3 (March 2013): 418-428.e1. https://doi.org/10.1016/j.ajo.2012.09.025.Full Text Link to Item
-
Nguyen, Quan Dong, Peter A. Campochiaro, Syed Mahmood Shah, David J. Browning, Henry L. Hudson, Peter L. Sonkin, Seenu M. Hariprasad, et al. “Evaluation of very high- and very low-dose intravitreal aflibercept in patients with neovascular age-related macular degeneration.” J Ocul Pharmacol Ther 28, no. 6 (December 2012): 581–88. https://doi.org/10.1089/jop.2011.0261.Full Text Link to Item
-
Diabetic Retinopathy Clinical Research Network, D. K., N. M. Bressler, K. M. Miller, R. W. Beck, S. B. Bressler, A. R. Glassman, J. W. Kitchens, M. Melia, and D. K. Schlossman. “Observational study of subclinical diabetic macular edema.” Eye (Lond) 26, no. 6 (June 2012): 833–40. https://doi.org/10.1038/eye.2012.53.Full Text Link to Item
-
Elman, M. J., M. D. Sloan, J. A. Starr, T. M. Butcher, P. V. Singletary, N. Gore, T. Coffey, et al. “Erratum: Observational study of subclinical diabetic macular edema (Eye (2012) 26, (833-840) DOI:10.1038/eye.2012.53).” Eye (Basingstoke) 26, no. 6 (June 1, 2012): 900–901. https://doi.org/10.1038/eye.2012.83.Full Text
-
Browning, D. J. “Anti-vascular endothelial growth factor treatment in retinal vein occlusions.” Current Drug Therapy 7, no. 2 (January 1, 2012): 101–16. https://doi.org/10.2174/157488512800675986.Full Text
-
Browning, D. J., P. K. Kaiser, P. J. Rosenfeld, and M. W. Stewart. “Aflibercept for age-related macular degeneration: A game-changer or quiet addition?” American Journal of Ophthalmology 154, no. 2 (January 1, 2012): 222–26. https://doi.org/10.1016/j.ajo.2012.04.020.Full Text
-
Diabetic Retinopathy Clinical Research Network, Trexler M., Trexler M. Writing Committee, Lloyd Paul Aiello, Roy W. Beck, Neil M. Bressler, David J. Browning, K. V. Chalam, et al. “Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema.” Ophthalmology 118, no. 12 (December 2011): e5-14. https://doi.org/10.1016/j.ophtha.2011.09.058.Full Text Link to Item
-
Browning, David J. “Interpreting thickness changes in the diabetic macula: the problem of short-term variation in optical coherence tomography-measured macular thickening (an american ophthalmological society thesis).” Trans Am Ophthalmol Soc 108 (December 2010): 62–76.Link to Item
-
Danis, Ronald P., Ingrid U. Scott, Haijing Qin, Michael M. Altaweel, Neil M. Bressler, Susan B. Bressler, David J. Browning, Craig Kollman, and Craig Diabetic Retinopathy Clinical Research Network. “Association of fluorescein angiographic features with visual acuity and with optical coherence tomographic and stereoscopic color fundus photographic features of diabetic macular edema in a randomized clinical trial.” Retina 30, no. 10 (2010): 1627–37. https://doi.org/10.1097/IAE.0b013e3181dde5f5.Full Text Link to Item
-
Nguyen, Quan Dong, Syed Mahmood Shah, David J. Browning, Henry Hudson, Peter Sonkin, Seenu M. Hariprasad, Peter Kaiser, et al. “A phase I study of intravitreal vascular endothelial growth factor trap-eye in patients with neovascular age-related macular degeneration.” Ophthalmology 116, no. 11 (November 2009): 2141-8.e1. https://doi.org/10.1016/j.ophtha.2009.04.030.Full Text Link to Item
-
Scott, Ingrid U., Ronald P. Danis, Susan B. Bressler, Neil M. Bressler, David J. Browning, Haijing Qin, and Haijing Diabetic Retinopathy Clinical Research Network. “Effect of focal/grid photocoagulation on visual acuity and retinal thickening in eyes with non-center-involved diabetic macular edema.” Retina 29, no. 5 (May 2009): 613–17. https://doi.org/10.1097/IAE.0b013e3181a2c07a.Full Text Link to Item
-
Browning, David J., Rajendra S. Apte, Susan B. Bressler, Kakarla V. Chalam, Ronald P. Danis, Matthew D. Davis, Craig Kollman, et al. “Association of the extent of diabetic macular edema as assessed by optical coherence tomography with visual acuity and retinal outcome variables.” Retina 29, no. 3 (March 2009): 300–305. https://doi.org/10.1097/IAE.0b013e318194995d.Full Text Link to Item
-
Do, D. V., Q. D. Nguyen, S. M. Shah, D. J. Browning, J. A. Haller, K. Chu, K. Yang, et al. “An exploratory study of the safety, tolerability and bioactivity of a single intravitreal injection of vascular endothelial growth factor Trap-Eye in patients with diabetic macular oedema.” Br J Ophthalmol 93, no. 2 (February 2009): 144–49. https://doi.org/10.1136/bjo.2008.138271.Full Text Link to Item
-
Glassman, Adam R., Roy W. Beck, David J. Browning, Ronald P. Danis, Craig Kollman, and Craig Diabetic Retinopathy Clinical Research Network Study Group. “Comparison of optical coherence tomography in diabetic macular edema, with and without reading center manual grading from a clinical trials perspective.” Invest Ophthalmol Vis Sci 50, no. 2 (February 2009): 560–66. https://doi.org/10.1167/iovs.08-1881.Full Text Link to Item
-
Browning, David J., Michael M. Altaweel, Neil M. Bressler, Susan B. Bressler, Ingrid U. Scott, and Ingrid U. Diabetic Retinopathy Clinical Research Network. “Diabetic macular edema: what is focal and what is diffuse?” Am J Ophthalmol 146, no. 5 (November 2008): 649-655.e6. https://doi.org/10.1016/j.ajo.2008.07.013.Full Text Link to Item
-
Browning, David J. “The role of vitrectomy surgery in diabetic macular edema.” Retina 28, no. 9 (October 2008): 1366. https://doi.org/10.1097/IAE.0b013e318182b968.Full Text Link to Item
-
Browning, David J., Adam R. Glassman, Lloyd P. Aiello, Neil M. Bressler, Susan B. Bressler, Ronald P. Danis, Matthew D. Davis, et al. “Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema.” Ophthalmology 115, no. 8 (August 2008): 1366-1371.e1. https://doi.org/10.1016/j.ophtha.2007.12.004.Full Text Link to Item
-
Bressler, Neil M., Allison R. Edwards, Andrew N. Antoszyk, Roy W. Beck, David J. Browning, Antonio P. Ciardella, Ronald P. Danis, et al. “Retinal thickness on Stratus optical coherence tomography in people with diabetes and minimal or no diabetic retinopathy.” Am J Ophthalmol 145, no. 5 (May 2008): 894–901. https://doi.org/10.1016/j.ajo.2007.12.025.Full Text Link to Item
-
Browning, David J., Christina M. Fraser, and Bradley W. Propst. “The variation in optical coherence tomography-measured macular thickness in diabetic eyes without clinical macular edema.” Am J Ophthalmol 145, no. 5 (May 2008): 889–93. https://doi.org/10.1016/j.ajo.2008.01.007.Full Text Link to Item
-
Davis, Matthew D., Susan B. Bressler, Lloyd Paul Aiello, Neil M. Bressler, David J. Browning, Christina J. Flaxel, Donald S. Fong, et al. “Comparison of time-domain OCT and fundus photographic assessments of retinal thickening in eyes with diabetic macular edema.” Invest Ophthalmol Vis Sci 49, no. 5 (May 2008): 1745–52. https://doi.org/10.1167/iovs.07-1257.Full Text Link to Item
-
Browning, David J., Christina M. Fraser, and Stephen Clark. “The relationship of macular thickness to clinically graded diabetic retinopathy severity in eyes without clinically detected diabetic macular edema.” Ophthalmology 115, no. 3 (March 2008): 533-539.e2. https://doi.org/10.1016/j.ophtha.2007.06.042.Full Text Link to Item
-
Browning, D. J., and A. Glassman. “Author reply.” Ophthalmology 115, no. 2 (February 1, 2008): 417. https://doi.org/10.1016/j.ophtha.2007.08.019.Full Text
-
Browning, David J., and Christina M. Fraser. “The predictive value of patient and eye characteristics on the course of subclinical diabetic macular edema.” Am J Ophthalmol 145, no. 1 (January 2008): 149–54. https://doi.org/10.1016/j.ajo.2007.08.038.Full Text Link to Item
-
Scott, Ingrid U., Neil M. Bressler, Susan B. Bressler, David J. Browning, Clement K. Chan, Ronald P. Danis, Matthew D. Davis, Craig Kollman, Haijing Qin, and Haijing Diabetic Retinopathy Clinical Research Network Study Group. “Agreement between clinician and reading center gradings of diabetic retinopathy severity level at baseline in a phase 2 study of intravitreal bevacizumab for diabetic macular edema.” Retina 28, no. 1 (January 2008): 36–40. https://doi.org/10.1097/IAE.0b013e31815e9385.Full Text Link to Item
-
Browning, D. J., and C. M. Fraser. “Primary intraocular lymphoma mimicking multifocal choroiditis and panuveitis.” Eye (Lond) 21, no. 6 (June 2007): 880–81. https://doi.org/10.1038/sj.eye.6702756.Full Text Link to Item
-
Browning, D. J., and C. M. Fraser. “Reply to abnormalities on the multifocal electroretinogram may precede clinical signs of hydroxychloroquine retinotoxicity.” Eye (Lond) 21, no. 1 (January 2007): 147. https://doi.org/10.1038/sj.eye.6702477.Full Text Link to Item
-
Browning, David J., Christina M. Fraser, and Michele E. Powers. “Comparison of the magnitude and time course of macular thinning induced by different interventions for diabetic macular edema: implications for sequence of application.” Ophthalmology 113, no. 10 (October 2006): 1713–19. https://doi.org/10.1016/j.ophtha.2006.05.021.Full Text Link to Item
-
Browning, David J., Christina M. Fraser, and Michelle E. Powers. “A spreadsheet template for the analysis of optical coherence tomography in the longitudinal management of diabetic macular edema.” Ophthalmic Surg Lasers Imaging 37, no. 5 (2006): 399–405. https://doi.org/10.3928/15428877-20060901-07.Full Text Link to Item
-
Browning, David J., and Christina M. Fraser. “Combined central retinal vein and artery occlusion associated with an isolated superior ophthalmic vein thrombosis.” Retina 25, no. 6 (September 2005): 805. https://doi.org/10.1097/00006982-200509000-00026.Full Text Link to Item
-
Browning, David J., and Christina M. Fraser. “Regional patterns of sight-threatening diabetic macular edema.” Am J Ophthalmol 140, no. 1 (July 2005): 117–24. https://doi.org/10.1016/j.ajo.2005.02.032.Full Text Link to Item
-
Browning, David J., and Christina M. Fraser. “Ocular conditions associated with peripapillary subretinal neovascularization, their relative frequencies, and associated outcomes.” Ophthalmology 112, no. 6 (June 2005): 1054–61. https://doi.org/10.1016/j.ophtha.2004.11.062.Full Text Link to Item
-
Browning, David J., and Christina M. Fraser. “Clinical management of silicone intraocular lens condensation.” Am J Ophthalmol 139, no. 4 (April 2005): 740–42. https://doi.org/10.1016/j.ajo.2004.10.027.Full Text Link to Item
-
Lall, Ashish, Annie Mathai, and Ravi Thomas. “Diagnostic methods for macular edema.” Ophthalmology 112, no. 4 (April 2005): 734–35. https://doi.org/10.1016/j.ophtha.2004.10.001.Full Text Link to Item
-
Browning, David J., and Christina M. Fraser. “Intraobserver variability in optical coherence tomography.” Am J Ophthalmol 138, no. 3 (September 2004): 477–79. https://doi.org/10.1016/j.ajo.2004.03.014.Full Text Link to Item
-
Browning, David J. “Interobserver variability in optical coherence tomography for macular edema.” Am J Ophthalmol 137, no. 6 (June 2004): 1116–17. https://doi.org/10.1016/j.ajo.2003.12.013.Full Text Link to Item
-
Browning, David J., and Christina M. Fraser. “Retinal vein occlusions in patients taking warfarin.” Ophthalmology 111, no. 6 (June 2004): 1196–1200. https://doi.org/10.1016/j.ophtha.2003.09.047.Full Text Link to Item
-
Browning, David J. “West African crystalline maculopathy.” Ophthalmology 111, no. 5 (May 2004): 921–25. https://doi.org/10.1016/j.ophtha.2003.09.030.Full Text Link to Item
-
Browning, David J., and Christina M. Fraser. “Optical coherence tomography to detect macular edema in the presence of asteroid hyalosis.” Am J Ophthalmol 137, no. 5 (May 2004): 959–61. https://doi.org/10.1016/j.ajo.2003.11.049.Full Text Link to Item
-
Browning, David J., Michael D. McOwen, Robert M. Bowen, and Tisha L. O’Marah. “Comparison of the clinical diagnosis of diabetic macular edema with diagnosis by optical coherence tomography.” Ophthalmology 111, no. 4 (April 2004): 712–15. https://doi.org/10.1016/j.ophtha.2003.06.028.Full Text Link to Item
-
Browning, David J. “Patchy ischemic retinal whitening.” Ophthalmology 111, no. 3 (March 2004): 606–7. https://doi.org/10.1016/j.ophtha.2003.12.033.Full Text Link to Item
-
Browning, David J. “Bull's-eye maculopathy associated with quinacrine therapy for malaria.” Am J Ophthalmol 137, no. 3 (March 2004): 577–79. https://doi.org/10.1016/j.ajo.2003.08.047.Full Text Link to Item
-
Browning, David J. “Positioning the obese or large-breasted patient for macular laser photocoagulation.” Am J Ophthalmol 137, no. 1 (January 2004): 178–79. https://doi.org/10.1016/s0002-9394(03)00737-2.Full Text Link to Item
-
Browning, David J. “Dislocated ganciclovir implant from use of a nylon fixation suture.” Retina 23, no. 5 (October 2003): 723–24. https://doi.org/10.1097/00006982-200310000-00026.Full Text Link to Item
-
Sodhi, Punita Kumari. “Iris cyst secondary to latanoprost mimicking iris melanoma.” Am J Ophthalmol 136, no. 4 (October 2003): 780. https://doi.org/10.1016/s0002-9394(03)00580-4.Full Text Link to Item
-
Browning, David J. “Potential pitfalls from variable optical coherence tomograph displays in managing diabetic macular edema.” Am J Ophthalmol 136, no. 3 (September 2003): 555–57. https://doi.org/10.1016/s0002-9394(03)00387-8.Full Text Link to Item
-
Browning, David J. “Acute retinal necrosis following epidural steroid injections.” Am J Ophthalmol 136, no. 1 (July 2003): 192–94. https://doi.org/10.1016/s0002-9394(03)00095-3.Full Text Link to Item
-
Browning, David J. “Choroidal osteoma: observations from a community setting.” Ophthalmology 110, no. 7 (July 2003): 1327–34. https://doi.org/10.1016/S0161-6420(03)00458-5.Full Text Link to Item
-
Browning, David J., and Andrew N. Antoszyk. “Retinal tear and detachment after transpupillary thermotherapy for choroidal melanoma.” Am J Ophthalmol 135, no. 5 (May 2003): 729–30. https://doi.org/10.1016/s0002-9394(02)02111-6.Full Text Link to Item
-
Browning, David J., Stephen L. Perkins, and Kurt K. Lark. “Iris cyst secondary to latanoprost mimicking iris melanoma.” Am J Ophthalmol 135, no. 3 (March 2003): 419–21. https://doi.org/10.1016/s0002-9394(02)01953-0.Full Text Link to Item
-
Easterbrook, Michael. “Defining ideal body weight.” Am J Ophthalmol 134, no. 6 (December 2002): 935. https://doi.org/10.1016/s0002-9394(02)01799-3.Full Text Link to Item
-
Browning, David J. “Patchy ischemic retinal whitening in acute central retinal vein occlusion.” Ophthalmology 109, no. 11 (November 2002): 2154–59. https://doi.org/10.1016/s0161-6420(02)01217-4.Full Text Link to Item
-
Browning, David J. “Hydroxychloroquine and chloroquine retinopathy: screening for drug toxicity.” Am J Ophthalmol 133, no. 5 (May 2002): 649–56. https://doi.org/10.1016/s0002-9394(02)01392-2.Full Text Link to Item
-
Browning, D. J. “Posterior segment manifestations of active ocular syphilis, their response to a neurosyphilis regimen of penicillin therapy, and the influence of human immunodeficiency virus status on response.” Ophthalmology 107, no. 11 (November 2000): 2015–23. https://doi.org/10.1016/s0161-6420(00)00457-7.Full Text Link to Item
-
Browning, D. J. “Fundus photographic, fluorescein angiographic, and indocyanine green angiographic signs in successful laser chorioretinal venous anastomosis for central retinal vein occlusion.” Ophthalmology 106, no. 12 (December 1999): 2261–68. https://doi.org/10.1016/S0161-6420(99)90561-4.Full Text Link to Item
-
Browning, D. J., and A. N. Antoszyk. “The effect of the surgeon and the laser wavelength on the response to focal photocoagulation for diabetic macular edema.” Ophthalmology 106, no. 2 (February 1999): 243–48. https://doi.org/10.1016/S0161-6420(99)90063-5.Full Text Link to Item
-
Browning, D. J., A. Q. Scott, C. B. Peterson, J. Warnock, and Z. Zhang. “The risk of missing angle neovascularization by omitting screening gonioscopy in acute central retinal vein occlusion.” Ophthalmology 105, no. 5 (May 1998): 776–84. https://doi.org/10.1016/S0161-6420(98)95014-X.Full Text Link to Item
-
Browning, D. J., and A. N. Antoszyk. “Laser chorioretinal venous anastomosis for nonischemic central retinal vein occlusion.” Ophthalmology 105, no. 4 (April 1998): 670–77. https://doi.org/10.1016/S0161-6420(98)94022-2.Full Text Link to Item
-
Browning, D. J., Z. Zhang, J. M. Benfield, and A. Q. Scott. “The effect of patient characteristics on response to focal laser treatment for diabetic macular edema.” Ophthalmology 104, no. 3 (March 1997): 466–72. https://doi.org/10.1016/s0161-6420(97)30290-5.Full Text Link to Item
-
Browning, D. J., and M. H. Rotberg. “Vitreous Hemorrhage complicating laser-induced chorioretinal anastomosis for central retinal vein occlusion.” Am J Ophthalmol 122, no. 4 (October 1996): 588–89. https://doi.org/10.1016/s0002-9394(14)72128-2.Full Text Link to Item
-
Browning, D. J. “Nadolol in the treatment of central serous retinopathy.” Am J Ophthalmol 116, no. 6 (December 15, 1993): 770–71. https://doi.org/10.1016/s0002-9394(14)73483-x.Full Text Link to Item
-
Browning, D. J. “Mild frosted branch periphlebitis.” Am J Ophthalmol 114, no. 4 (October 15, 1992): 505–6. https://doi.org/10.1016/s0002-9394(14)71869-0.Full Text Link to Item
-
Browning, D. J. “Risk of missing angle neovascularization by omitting screening gonioscopy in patients with diabetes mellitus.” Am J Ophthalmol 112, no. 2 (August 15, 1991): 212. https://doi.org/10.1016/s0002-9394(14)76707-8.Full Text Link to Item
-
Browning, D. J., H. W. Flynn, and G. W. Blankenship. “Asymmetric retinopathy in patients with diabetes mellitus.” Am J Ophthalmol 105, no. 6 (June 15, 1988): 584–89. https://doi.org/10.1016/0002-9394(88)90048-7.Full Text Link to Item
-
Browning, D. J., and E. G. Buckley. “Reliability of brightness comparison testing in predicting afferent pupillary defects.” Arch Ophthalmol 106, no. 3 (March 1988): 341–43. https://doi.org/10.1001/archopht.1988.01060130367023.Full Text Link to Item
-
Browning, D. J., M. S. Blumenkranz, W. W. Culbertson, J. D. Clarkson, Y. Tardif, A. Gourdeau, and J. Minturn. “Association of Varicella Zoster Dermatitis with acute Retinal Necrosis Syndrome.” Ophthalmology 94, no. 6 (January 1, 1987): 602–6. https://doi.org/10.1016/S0161-6420(87)33405-0.Full Text
-
Browning, D. J., and J. S. Tiedeman. “Author's reply.” Ophthalmology 94, no. 10 (January 1, 1987): 1362. https://doi.org/10.1016/S0161-6420(87)80026-X.Full Text
-
Browning, D. J., and J. S. Tiedeman. “The test light affects quantitation of the afferent pupillary defect.” Ophthalmology 94, no. 1 (January 1987): 53–55. https://doi.org/10.1016/s0161-6420(87)33503-1.Full Text Link to Item
-
Browning, D., G. Rosenwasser, and M. Lugo. “Reply.” American Journal of Ophthalmology 102, no. 2 (August 15, 1986): 284. https://doi.org/10.1016/0002-9394(86)90169-8.Full Text
-
Hill, J. A., J. L. Trantham, D. J. Browning, A. O. Grant, and H. C. Strauss. “An upper limit for the electrogenic Na-K pump contribution to maximum diastolic potential in feline cardiac Purkinje fibers in steady state.” Can J Physiol Pharmacol 64, no. 5 (May 1986): 641–48. https://doi.org/10.1139/y86-106.Full Text Link to Item
-
Browning, D. J., G. Rosenwasser, and M. Lugo. “Ocular rosacea in blacks.” Am J Ophthalmol 101, no. 4 (April 15, 1986): 441–44. https://doi.org/10.1016/0002-9394(86)90644-6.Full Text Link to Item
-
Browning, D. J., and A. D. Proia. “Ocular rosacea.” Surv Ophthalmol 31, no. 3 (1986): 145–58. https://doi.org/10.1016/0039-6257(86)90034-2.Full Text Link to Item
-
Browning, D. J., and L. M. Cobo. “Letter to the Editor.” Ophthalmology 93, no. 8 (January 1, 1986): 1124. https://doi.org/10.1016/S0161-6420(86)33814-4.Full Text
-
Browning, D. J., and L. M. Cobo. “Early experience in extracapsular cataract surgery by residents.” Ophthalmology 92, no. 12 (December 1985): 1647–53. https://doi.org/10.1016/s0161-6420(85)33976-3.Full Text Link to Item
-
Browning, D. J. “Reply.” American Journal of Ophthalmology 100, no. 5 (November 15, 1985): 743–44. https://doi.org/10.1016/0002-9394(85)90640-3.Full Text
-
Browning, D. J. “Tear studies in ocular rosacea.” Am J Ophthalmol 99, no. 5 (May 15, 1985): 530–33. https://doi.org/10.1016/s0002-9394(14)77951-6.Full Text Link to Item
-
Browning, D. J., A. D. Proia, and F. P. Sanfilippo. “Pyoderma gangrenosum involving the eyelid.” Arch Ophthalmol 103, no. 4 (April 1985): 551–52. https://doi.org/10.1001/archopht.1985.01050040093027.Full Text Link to Item
-
Proia, A. D., D. J. Browning, and G. K. Klintworth. “Actinic granuloma of the conjunctiva.” Am J Ophthalmol 96, no. 1 (July 1983): 116–18. https://doi.org/10.1016/0002-9394(83)90474-9.Full Text Link to Item
-
Browning, D. J., T. Guarnieri, and H. C. Strauss. “Ouabain effects on intracellular potassium activity and contractile force in cat papillary muscle.” J Clin Invest 68, no. 4 (October 1981): 942–56. https://doi.org/10.1172/jci110349.Full Text Link to Item
-
Browning, D. J., and H. C. Strauss. “Effects of stimulation frequency on potassium activity and cell volume in cardiac tissue.” Am J Physiol 240, no. 1 (January 1981): C39–55. https://doi.org/10.1152/ajpcell.1981.240.1.C39.Full Text Link to Item
-
TRANTHAM, J. L., D. J. BROWNING, A. O. GRANT, A. G. WALLACE, and H. C. STRAUSS. “MEASUREMENT OF THE SODIUM-POTASSIUM EXCHANGE PUMP COUPLING RATIO IN FELINE PURKINJE-FIBERS.” Clinical Research 29, no. 2 (January 1, 1981): A246–A246.Link to Item
-
TRANTHAM, J. L., D. J. BROWNING, A. O. GRANT, A. G. WALLACE, and H. C. STRAUSS. “COUPLING RATIO OF THE SODIUM-POTASSIUM EXCHANGE PUMP IN CARDIAC TISSUE.” Federation Proceedings 40, no. 3 (January 1, 1981): 392–392.Link to Item
-
Kerr, C. R., E. N. Prystowsky, D. J. Browning, and H. C. Strauss. “Characterization of refractoriness in the sinus node of the rabbit.” Circ Res 47, no. 5 (November 1980): 742–56. https://doi.org/10.1161/01.res.47.5.742.Full Text Link to Item
-
Wenger, T. L., D. J. Browning, C. E. Masterton, M. B. Abou-Donia, F. E. Harrell, R. J. Bache, and H. C. Strauss. “Procainamide delivery to ischemic canine myocardium following rapid intravenous administration.” Circ Res 46, no. 6 (June 1980): 789–95. https://doi.org/10.1161/01.res.46.6.789.Full Text Link to Item
-
BROWNING, D. J., C. R. KERR, and H. C. STRAUSS. “ELECTROCHEMICAL ANATOMY OF THE RABBIT RIGHT ATRIUM - POTASSIUM.” Circulation 62, no. 4 (January 1, 1980): 54–54.Link to Item
-
BROWNING, D. J., T. GUARNIERI, and H. C. STRAUSS. “OUABAIN EFFECTS ON CONTRACTILE-FORCE AND INTRACELLULAR POTASSIUM ACTIVITY (ALPHA-KI).” Circulation 62, no. 4 (January 1, 1980): 282–282.Link to Item
-
BROWNING, D. J., and H. C. STRAUSS. “EFFECTS OF SUDDEN INCREASES IN STIMULATION FREQUENCY ON INTRACELLULAR POTASSIUM ACTIVITY AND CELL-VOLUME IN FELINE VENTRICULAR MUSCLE.” Federation Proceedings 39, no. 3 (January 1, 1980): 817–817.Link to Item
-
BROWNING, D. J., and H. C. STRAUSS. “EXISTENCE OF A GRADIENT IN INTRACELLULAR POTASSIUM ACTIVITY AT PURKINJE FIBER-VENTRICULAR MUSCLE JUNCTIONS.” Clinical Research 28, no. 2 (January 1, 1980): A159–A159.Link to Item
-
Browning, D. J., T. Guarnieri, and H. C. Strauss. “Ouabain effects on contractile force and intracellular potassium activity (αi/K).” Circulation 62, no. 4 II (January 1, 1980).
-
KERR, C. R., D. J. BROWNING, P. C. DOLBER, and H. C. STRAUSS. “POTASSIUM ACTIVITY IN RABBIT SINUS NODE.” Circulation 62, no. 4 (January 1, 1980): 54–54.Link to Item
-
Browning, D. J., J. S. Tiedeman, A. L. Stagg, D. G. Benditt, M. M. Scheinman, and H. C. Strauss. “Aspects of rate-related hyperpolarization in feline Purkinje fibers.” Circ Res 44, no. 5 (May 1979): 612–24. https://doi.org/10.1161/01.res.44.5.612.Full Text Link to Item
-
BENDITT, D. “Effect of reduced pO2 on rate-related hyperpolarization in feline Purkinje strands.” Journal of Molecular and Cellular Cardiology 11 (April 1979): 6–6. https://doi.org/10.1016/0022-2828(79)90112-3.Full Text
-
WENGER, T. L., D. J. BROWNING, C. E. MASTERTON, M. B. ABOUDONIA, F. E. HARRELL, R. J. BACHE, and H. C. STRAUSS. “EFFECTS OF ISCHEMIA ON KINETICS OF MYOCARDIAL PROCAINAMIDE CONCENTRATION.” Federation Proceedings 38, no. 3 (January 1, 1979): 531–531.Link to Item
-
Wenger, T. L., D. J. Browning, and C. E. Masterton. “Procainamide concentration in ischemic myocardium following single and periodic bolus administration.” Clinical Research 27, no. 2 (January 1, 1979).
-
Wenger, T. L., D. J. Browning, and C. E. Masterton. “Effects of ischemia on kinetics of myocardial procainamide concentration.” Federation Proceedings 38, no. 3 I (January 1, 1979).
-
-
Book Sections
-
Bhavsar, A. R., G. G. Emerson, M. V. Emerson, and D. J. Browning. “Epidemiology of diabetic retinopathy.” In Diabetic Retinopathy: Evidence-Based Management, 53–75, 2010. https://doi.org/10.1007/978-0-387-85900-2_3.Full Text
-
Browning, D. J. “Screening for diabetic retinopathy.” In Diabetic Retinopathy: Evidence-Based Management, 369–85, 2010. https://doi.org/10.1007/978-0-387-85900-2_14.Full Text
-
Browning, D. J. “Systemic and ocular factors influencing diabetic retinopathy.” In Diabetic Retinopathy: Evidence-Based Management, 77–103, 2010. https://doi.org/10.1007/978-0-387-85900-2_4.Full Text
-
Browning, D. J. “Practical concerns with ethical dimensions in the management of diabetic retinopathy.” In Diabetic Retinopathy: Evidence-Based Management, 387–401, 2010. https://doi.org/10.1007/978-0-387-85900-2_15.Full Text
-
Browning, D. J. “Cataract surgery and diabetic retinopathy.” In Diabetic Retinopathy: Evidence-Based Management, 305–23, 2010. https://doi.org/10.1007/978-0-387-85900-2_10.Full Text
-
Browning, D. J. “Optic nerve disease in diabetes mellitus.” In Diabetic Retinopathy: Evidence-Based Management, 357–68, 2010. https://doi.org/10.1007/978-0-387-85900-2_13.Full Text
-
Browning, D. J. “Diabetic macular edema.” In Diabetic Retinopathy: Evidence-Based Management, 141–202, 2010. https://doi.org/10.1007/978-0-387-85900-2_7.Full Text
-
Browning, D. J., S. E. Pautler, D. G. Telander, K. Wong, M. W. Stewart, and A. R. Bhavsar. “Clinical examples in managing diabetic retinopathy.” In Diabetic Retinopathy: Evidence-Based Management, 403–39, 2010. https://doi.org/10.1007/978-0-387-85900-2_16.Full Text
-
Browning, D. J., and M. H. Rotberg. “The relationship of diabetic retinopathy and glaucoma.” In Diabetic Retinopathy: Evidence-Based Management, 325–46, 2010. https://doi.org/10.1007/978-0-387-85900-2_11.Full Text
-
Telander, D. G., K. W. Small, and D. J. Browning. “Genetics and diabetic retinopathy.” In Diabetic Retinopathy: Evidence-Based Management, 31–52, 2010. https://doi.org/10.1007/978-0-387-85900-2_2.Full Text
-
-
Conference Papers
-
Scott, Ingrid U., Paul C. VanVeldhuisen, Michael S. Ip, Barbara A. Blodi, Neal L. Oden, Michael Altaweel, Daniel M. Berinstein, and Daniel M. SCORE2 Investigator Group. “Comparison of Monthly vs Treat-and-Extend Regimens for Individuals With Macular Edema Who Respond Well to Anti-Vascular Endothelial Growth Factor Medications: Secondary Outcomes From the SCORE2 Randomized Clinical Trial.” In Jama Ophthalmol, 136:337–45, 2018. https://doi.org/10.1001/jamaophthalmol.2017.6843.Full Text Link to Item
-
Campochiaro, Peter A., Raafay Sophie, Michael Tolentino, Daniel M. Miller, David Browning, David S. Boyer, Jeffrey S. Heier, et al. “Treatment of diabetic macular edema with an inhibitor of vascular endothelial-protein tyrosine phosphatase that activates Tie2.” In Ophthalmology, 122:545–54, 2015. https://doi.org/10.1016/j.ophtha.2014.09.023.Full Text Link to Item
-
-
Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.